Lombard Odier Asset Management (Switzerland) Sa Eli Lilly & CO Transaction History

Lombard Odier Asset Management (Switzerland) Sa

$1.14 Billion
Q3 2024

A detailed history of Lombard Odier Asset Management (Switzerland) Sa transactions in Eli Lilly & CO stock. As of the latest transaction made, Lombard Odier Asset Management (Switzerland) Sa holds 21,314 shares of LLY stock, worth $17 Million. This represents 1.65% of its overall portfolio holdings.

Number of Shares

21,314

Previous 19,066 11.79%

Holding current value

$17 Million

Previous $17.3 Million 9.39%

% of portfolio

1.65%

Previous 1.77%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$772.14 - $960.02 $1.74 Million - $2.16 Million	2,248 Added 11.79%	21,314 $18.9 Million
Q2 2024 Aug 14, 2024	SELL	$724.87 - $909.04 $12.3 Million - $15.5 Million	-17,035 Reduced 47.19%	19,066 $17.3 Million
Q1 2024 May 15, 2024	BUY	$592.2 - $792.28 $5.85 Million - $7.82 Million	9,873 Added 37.64%	36,101 $28.1 Million
Q4 2023 Feb 14, 2024	SELL	$525.19 - $619.13 $1.85 Million - $2.18 Million	-3,524 Reduced 11.84%	26,228 $15.3 Million
Q3 2023 Nov 14, 2023	SELL	$434.7 - $599.3 $2.67 Million - $3.68 Million	-6,138 Reduced 17.1%	29,752 $16 Million
Q2 2023 Aug 14, 2023	SELL	$350.74 - $468.98 $3.34 Million - $4.47 Million	-9,536 Reduced 20.99%	35,890 $16.8 Million
Q1 2023 May 15, 2023	BUY	$310.63 - $364.82 $5.25 Million - $6.17 Million	16,903 Added 59.26%	45,426 $15.6 Million
Q4 2022 Feb 14, 2023	BUY	$321.55 - $374.67 $7.98 Million - $9.29 Million	24,806 Added 667.37%	28,523 $10.4 Million
Q3 2022 Nov 14, 2022	SELL	$296.48 - $337.87 $74,416 - $84,805	-251 Reduced 6.33%	3,717 $1.2 Million
Q2 2022 Aug 15, 2022	BUY	$278.73 - $327.27 $1.11 Million - $1.3 Million	3,968 New	3,968 $1.29 Million
Q1 2022 May 16, 2022	SELL	$234.69 - $291.66 $1.07 Million - $1.33 Million	-4,546 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$224.85 - $279.04 $1.02 Million - $1.27 Million	4,546 New	4,546 $1.26 Million
Q3 2021 Nov 12, 2021	SELL	$221.6 - $272.71 $1.09 Million - $1.35 Million	-4,941 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$180.55 - $233.54 $218,104 - $282,116	1,208 Added 32.36%	4,941 $1.13 Million
Q1 2021 May 17, 2021	BUY	$164.32 - $212.72 $613,406 - $794,083	3,733 New	3,733 $697,000
Q4 2020 Feb 16, 2021	SELL	$130.46 - $172.63 $1.36 Million - $1.8 Million	-10,418 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$146.22 - $169.13 $1.52 Million - $1.76 Million	10,418 New	10,418 $1.54 Million
Q2 2020 Aug 14, 2020	SELL	$136.42 - $164.18 $1.66 Million - $2 Million	-12,174 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$119.05 - $147.35 $779,539 - $964,847	-6,548 Reduced 34.97%	12,174 $1.69 Million
Q4 2019 Feb 14, 2020	BUY	$106.92 - $132.43 $589,129 - $729,689	5,510 Added 41.7%	18,722 $2.46 Million
Q3 2019 Nov 14, 2019	SELL	$106.79 - $116.16 $1.43 Million - $1.56 Million	-13,436 Reduced 50.42%	13,212 $1.48 Million
Q2 2019 Aug 14, 2019	BUY	$110.79 - $129.32 $6,868 - $8,017	62 Added 0.23%	26,648 $2.95 Million
Q1 2019 May 15, 2019	SELL	$111.31 - $131.02 $12.2 Million - $14.3 Million	-109,373 Reduced 80.45%	26,586 $3.45 Million
Q4 2018 Feb 14, 2019	BUY	$105.9 - $118.64 $13.6 Million - $15.3 Million	128,674 Added 1766.29%	135,959 $15.7 Million
Q3 2018 Nov 14, 2018	BUY	$85.86 - $107.31 $340,005 - $424,947	3,960 Added 119.1%	7,285 $782,000
Q1 2018 May 15, 2018	SELL	$74.21 - $87.6 $141,073 - $166,527	-1,901 Reduced 36.38%	3,325 $257,000
Q3 2017 Nov 14, 2017	BUY	$77.07 - $85.54 $402,767 - $447,032	5,226	5,226 $447,000

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $756B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lombard Odier Asset Management (Switzerland) Sa, based on Form 13F filings with the SEC.

News

Stay updated on Lombard Odier Asset Management (Switzerland) Sa with notifications on news.

Account

Lombard Odier Asset Management (Switzerland) Sa Eli Lilly & CO Transaction History